Cancer

Our team of cancer researchers is involved in research to improve cancer screening, prevention, treatment, survival and costs for Kaiser Permanente members and for the nation. We evaluate a variety of patient reported results and other factors to improve cancer-related care and improve quality of life for cancer survivors. We conduct research to evaluate how health system policies and processes affect care for cancer patients. Additionally, the IHR partners with local and national organizations, including the National Cancer Institute, to develop cohorts of study participants who are interested in taking part in research aimed at preventing cancer or improving cancer-related results.


Cancer Researchers


Featured Projects

Investigators: Debra P. Ritzwoller, PhD and Andrea Burnett-Hartman, PhD, MPH
The long-term goal of this multi-site center grant is to identify critical gaps in the lung cancer screening process and to design innovative, multilevel interventions to reduce lung cancer mortality, particularly among underserved populations.
Funder: National Cancer Institute
Study End Date: 03/31/2023
Investigator: Andrea Burnett-Hartman, PhD, MPH
Recent evidence implicates an additional group of polyps, sessile serrated polyps, as potential precursors to a subset of colorectal cancer. This project investigated the clinical significance of sessile serrated polyps, with the long-term goal of identifying new groups that are high-risk for colorectal cancer and improving the effectiveness of colorectal cancer screening.
Funder: National Cancer Institute
Study End Date: 03/31/2018
Investigator: Heather Spencer Feigelson, PhD, MPH
The goal of this project was to investigate the association between breast density and risk of contralateral breast cancer.
Funder: National Cancer Institute
Study End Date: 07/31/2019
Investigator: Andrea Burnett-Hartman, PhD, MPH
The goal of the PROSPR Coordinating Center (PCC) is to coordinate the research of PROSPR Research Centers to achieve PROSPR's mission of evaluating and improving the cancer screening process (recruitment, screening, diagnosis, and referral for treatment).
Funder: National Cancer Institute
Study End Date: 03/31/2023
Investigator: Heather Spencer Feigelson, PhD, MPH
The Connect study is a collaboration of 3 Kaiser Permanente (KP) regions (KPCO, KPNW and KPHI) and other integrated healthcare systems within the U.S. to participate in a prospective multi-center cohort study that will enroll 150,000-200,000 cancer-free adults. This cohort will provide a powerful platform for studying the etiology, prevention, and early detection of cancer.
Funder: National Cancer Institute
Study End Date: 06/03/2028
Investigator: Debra P. Ritzwoller, PhD
Funder: National Cancer Institute
Study End Date: 02/28/2019
Investigator: Debra P. Ritzwoller, PhD
Funder: Patient-Centered Outcomes Research Institute
Study End Date: 07/31/2020
Investigator: Debra P. Ritzwoller, PhD
Funder: American Cancer Society
Study End Date: 06/30/2021